NCT04254471 2020-02-05This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in PatientsHaihe Biopharma Co., Ltd.Phase 2/3 Unknown313 enrolled
NCT03260179 2017-08-24Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810Haihe Biopharma Co., Ltd.Phase 1 Unknown60 enrolled